Skip to main content
Multiple Myeloma, Venetoclax
BELLINI Study: Venetoclax versus Placebo in Combination with Bortezomib/Dexamethasone in Patients with RRMM
Read More
Multiple Myeloma
Melflufen plus Dexamethasone and Daratumumab or Bortezomib
Read More
Multiple Myeloma, Monoclonal Antibodies
HORIZON: Use of Melflufen plus Dexamethasone in Patients with RRMM Refractory to Pomalidomide and/or an Anti-CD38 Monoclonal Antibody
Read More
Multiple Myeloma
Patients with Newly Diagnosed Transplant-Eligible MM and Minimal Residual Disease after Treatment with Ixazomib, Lenalidomide, and Dexamethasone
Read More
Multiple Myeloma
TOURMALINE-MM4 Study: Patients with NDMM Not Treated with Stem-Cell Transplantation and Maintenance Therapy with Ixazomib
Read More
Multiple Myeloma
FORTE Trial: Analysis of Survival in Patients with Newly Diagnosed Transplant-Eligible MM
Read More
Multiple Myeloma
In Newly Diagnosed, Transplant-Eligible Patients with MM, Consolidation Treatment with VRD Followed by Lenalidomide Maintenance versus Maintenance Alone
Read More
Multiple Myeloma
GEM-POMCIDEX Study: Treatment of Patients with RRMM Using Pomalidomide, Cyclophosphamide, and Dexamethasone (POMCIDEX)
Read More
Multiple Myeloma
Assessment of Options for Patients with RRMM with Triple-Class Exposure: Literature Review Indicates Urgent Need for New Treatments
Read More
Multiple Myeloma
Definition and Prediction of Unsustained Complete Remission in Patients with Transplant-Eligible MM
Read More
Page 101 of 200
Results 1001 - 1010 of 1993